您的位置: 首页 > 农业专利 > 详情页

Bridged bicyclic inhibitors of menin-MLL and methods of use
专利权人:
Inc.;The Regents of the University of Michigan;Kura Oncology, Inc.;Kura Oncology
发明人:
Wu, Tao,Li, Liansheng,Wang, Yi,Ren, Pingda,Grembecka, Jolanta,Cierpicki, Tomasz,Klossowski, Szymon,Pollock, Jonathan,Borkin, Dmitry
申请号:
AU2017235462
公开号:
AU2017235462A1
申请日:
2017.03.15
申请国别(地区):
AU
年份:
2018
代理人:
摘要:
The present disclosure provides methods of inhibiting the interaction of menin with MLL1, MLL2 and MLL-fusion oncoproteins. The methods are useful for the treatment of leukemia, solid cancers, diabetes and other diseases dependent on activity of MLL1, MLL2, MLL fusion proteins, and/or menin. Compositions for use in these methods are also provided.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充